195 related articles for article (PubMed ID: 30706394)
1. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration.
Tinch S; Szczur K; Swaney W; Reeves L; Witting SR
Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394
[TBL] [Abstract][Full Text] [Related]
2. Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting.
Dasgupta A; Tinch S; Szczur K; Ernst R; Shryock N; Kaylor C; Lewis K; Day E; Truong T; Swaney W
Methods Mol Biol; 2020; 2086():27-60. PubMed ID: 31707666
[TBL] [Abstract][Full Text] [Related]
3. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral Vector Bioprocessing.
Perry C; Rayat ACME
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
[TBL] [Abstract][Full Text] [Related]
5. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
6. Toward a Scalable Purification Protocol of GaLV-TR-Pseudotyped Lentiviral Vectors.
Boudeffa D; Bertin B; Biek A; Mormin M; Leseigneur F; Galy A; Merten OW
Hum Gene Ther Methods; 2019 Oct; 30(5):153-171. PubMed ID: 31516018
[TBL] [Abstract][Full Text] [Related]
7. Lentivirus Production and Purification.
Benskey MJ; Manfredsson FP
Methods Mol Biol; 2016; 1382():107-14. PubMed ID: 26611582
[TBL] [Abstract][Full Text] [Related]
8. Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration.
Cooper AR; Patel S; Senadheera S; Plath K; Kohn DB; Hollis RP
J Virol Methods; 2011 Oct; 177(1):1-9. PubMed ID: 21784103
[TBL] [Abstract][Full Text] [Related]
9. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
10. Generation of High-Titer Pseudotyped Lentiviral Vectors.
Hu S; Li M; Akkina R
Methods Mol Biol; 2019; 1937():125-134. PubMed ID: 30706393
[TBL] [Abstract][Full Text] [Related]
11. [A novel system for producing lentiviral vectors].
Ma Q; Li M; Dong WQ; Wu YS
Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):958-60. PubMed ID: 18051882
[TBL] [Abstract][Full Text] [Related]
12. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.
Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M
J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417
[TBL] [Abstract][Full Text] [Related]
13. Generation of stable suspension producer cell lines for serum-free lentivirus production.
Klimpel M; Terrao M; Bräuer M; Dersch H; Biserni M; Melo Do Nascimento L; Schwingal S; Vogel JE; Ferlemann C; Brandt T; Lal NI; Bridgeman K; Petzke A; McDwyer E; Lim JL; Oh S; Brumatti G; Garcia Minambres A; Otte E; Noll T; Pirzas V; Laux H
Biotechnol J; 2024 May; 19(5):e2400090. PubMed ID: 38719592
[TBL] [Abstract][Full Text] [Related]
14. Production and purification of lentiviral vectors.
Tiscornia G; Singer O; Verma IM
Nat Protoc; 2006; 1(1):241-5. PubMed ID: 17406239
[TBL] [Abstract][Full Text] [Related]
15. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.
Lesch HP; Laitinen A; Peixoto C; Vicente T; Makkonen KE; Laitinen L; Pikkarainen JT; Samaranayake H; Alves PM; Carrondo MJ; Ylä-Herttuala S; Airenne KJ
Gene Ther; 2011 Jun; 18(6):531-8. PubMed ID: 21248790
[TBL] [Abstract][Full Text] [Related]
16. Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application.
Merten OW; Charrier S; Laroudie N; Fauchille S; Dugué C; Jenny C; Audit M; Zanta-Boussif MA; Chautard H; Radrizzani M; Vallanti G; Naldini L; Noguiez-Hellin P; Galy A
Hum Gene Ther; 2011 Mar; 22(3):343-56. PubMed ID: 21043787
[TBL] [Abstract][Full Text] [Related]
17. Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography.
Kutner RH; Puthli S; Marino MP; Reiser J
BMC Biotechnol; 2009 Feb; 9():10. PubMed ID: 19220915
[TBL] [Abstract][Full Text] [Related]
18. Generation of lentiviral vectors for use in skeletal muscle research.
Pichavant C; Tremblay JP
Methods Mol Biol; 2012; 798():285-95. PubMed ID: 22130843
[TBL] [Abstract][Full Text] [Related]
19. Gene Transfer into Pluripotent Stem Cells via Lentiviral Transduction.
Naujok O; Diekmann U; Elsner M
Methods Mol Biol; 2016; 1341():67-85. PubMed ID: 25762298
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer.
Yamada K; McCarty DM; Madden VJ; Walsh CE
Biotechniques; 2003 May; 34(5):1074-8, 1080. PubMed ID: 12765034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
